Cell Banking & Regeneration
Clinical Intelligence Hub • Expert Curation
Cellular preservation is the cornerstone of modern precision longevity protocols. By leveraging autologous stem cell storage (including Mesenchymal Stem Cells and Hair Follicle Stem Cells) and advanced natural killer (NK) cell immunotherapies, we aim to safeguard your biological assets at their peak vitality. The briefings below review clinical trials and publications establishing the efficacy of cell banking, tissue rejuvenation, and cell-based interventions.
A first-in-human pilot study evaluates the safety and clinical stem cell efficacy of Wharton's jelly-derived stem cell therapy for urethral strictures.
Recent research reveals that CD200-negative cell subpopulations in the hair follicle bulge possess superior regenerative capacity for follicular cellular therapy.
Persistent mutations in alveolar progenitor cells explain why lung adenocarcinoma risk remains high after smoking cessation, revealing tissue-specific repair.
See how hair follicle stem cell-derived exosomes and miR-181a-5p act as a cell-free therapy to switch dormant hair follicles into active growth phases.
Discover how stem cell-derived CAR-NK cells target MUC1 in esophageal cancer immunotherapy, offering a highly precise, off-the-shelf clinical treatment.
A proof-of-concept study links CD63-expressing small extracellular vesicles in cord blood serum to stem cell percentage, suggesting a potential new biomarker.
Does exosome therapy for hair loss work? A new preclinical study compares plant exosomes, human secretomes, and hybrid formulations for hair growth.
Discover how serum-free hair follicle mesenchymal stem cells repair joint cartilage.
A comparative preclinical study evaluates how preserving the native extracellular matrix may pave the way for improving future clinical stem cell efficacy.